Valuation
- Market cap
- 991,000
- Revenue TTM
- $0
- Net income TTM
- $-690,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- -0.03
Trading
- Volume
- 100
- Avg volume
- 1,472
- Day's range
- $0.08 – $0.08
- Shares out
- 7,242,000
- Stochastic %K
- 7%
- Beta
- -0.69
- Analysts
- —
- Price target
- —
Company profile
Mosaic ImmunoEngineering, Inc., a development-stage biotechnology company, focuses on advancing and commercialization of immunotherapies for the treatment of cancer. The company engages in pursuing new product candidates and platforms to build a pipeline based on immunotherapies. Mosaic ImmunoEngineering, Inc. was founded in 2020 and is based in Huntington Beach, California.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 657 208 0890
- Website
- https://www.mosaicie.com
- Address
- 9114 Adams Avenue, Suite 202, Huntington Beach, United States
Latest news
No headlines yet.
